All results

6 results for impact

• High Risk Prostate CA: Less Intense Tx for Low Risk Scores and More Intense Tx for High Risk Scores

  This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high…

  Ages

  18 Years - N/A

  Sexes

  Male

• ProACT Post-Approval Study

  The ProACT Post Approval Study is a 5-year prospective, open-label, multi-center study designed to evaluate the long-term incidence of urethral stricture and…

  Ages

  50 Years - N/A

  Sexes

  Male

• Givinostat Long Term Study

  This is an open label, long-term safety, tolerability, and efficacy study of GIVINOSTAT in all DMD (Duchenne's muscular dystrophy) patients who have been…

  Ages

  7 Years - N/A

  Sexes

  Male

• Solid - SGT - 001

  This is a controlled, open-label, single-ascending dose study to evaluate the safety, tolerability and efficacy of SGT-001 in adolescents and children with…

  Ages

  4 Years - 17 Years

  Sexes

  Male

• Sarepta 4658-402

  **This study will be comprised of 2 parts:** Part 1 (dose escalation) will be conducted to evaluate the safety and tolerability of 2 doses (100…

  Ages

  4 Years - 13 Years

  Sexes

  Male

• Edgewise-201 (CANYON)

  A study of EDG-5506 in Becker muscular dystrophy (known as CANYON) and pivotal cohort (known as GRAND CANYON). The EDG-5506-201 CANYON study was expanded to…

  Ages

  12 Years - 50 Years

  Sexes

  Male